SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston C 1997 Sex steroids and bone mass in older men: Positive associations with serum estrogens and negative associations with androgens. J Clin Invest 100: 17551759.
  • 2
    Greendale GA, Edelstein S, Barrett-Connor E 1997 Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo study. J Bone Miner Res 12: 18331843.
  • 3
    Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL 1998 Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab 83: 22662274.
  • 4
    Center JR, Nguyen TV, Sambrook PN, Eisman JA 1999 Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 84: 36263635.
  • 5
    Amin S, Zhang Y, Sawin CT, Evans SR, Hannan MT, Kiel DP, Wilson PWF, Felson DT 2000 Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med 133: 951963.
  • 6
    Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F 2001 Bioavailable estradiol may be an important determinant of osteoporosis in men: The MINOS study. J Clin Endocrinol Metab 86: 192199.
  • 7
    Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM 2001 Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 86: 35553561.
  • 8
    Van Pottelbergh I, Goemaere S, Kaufman JM 2003 Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. J Clin Endocrinol Metab 88: 30753081.
  • 9
    Gennari L, Merlotti D, Martini G, Gonnelli S, Franci B, Campagna S, Lucani B, Canto ND, Valenti R, Gennari C, Nuti R 2003 Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J Clin Endocrinol Metab 88: 53275333.
  • 10
    Bouxsein ML 2001 Biomechanics of age-related fractures. In: MarcusR, FeldmanD, KelseyJ (eds.) Osteoporosis, 2nd ed. Academic Press, San Diego, CA, USA, pp. 509531.
  • 11
    Riggs BL, Melton LJ III, Robb RA, Camp JJ, Atkinson EJ, Peterson JM, Rouleau PA, McCollough CH, Bouxsein ML, Khosla S 2004 A population-based study of age and sex differences in bone volumetric density, size, geometry and structure at different skeletal sites. J Bone Miner Res 19: 19451954.
  • 12
    Camp JJ, Karwoski RA, Stacy MC, Atkinson EJ, Khosla S, Melton LJ III, Riggs BL, Robb RA 2004 A system for the analysis of whole-bone strength from helical CT images. Proc SPIE 5369: 7488.
  • 13
    Melton LJ III 1996 History of the Rochester Epidemiology Project. Mayo Clin Proc 71: 266274.
  • 14
    Cann CE 1988 Quantitative CT for determination of bone mineral density: A review. Radiology 166: 509522.
  • 15
    Kalender WA, Felsenberg D, Genant HK, Fischer M, Dequeker JV, Reeve J 1995 The European Spine Phantom—a tool for standardization and quality control in spinal bone mineral measurements by DXA and QCT. Eur J Radiol 20: 8392.
  • 16
    O'Connor S, Baker HWG, Dulmanis A, Hudson B 1973 The measurement of sex steroid binding globulin by differential ammonium sulphate precipitation. J Steroid Biochem 4: 331339.
  • 17
    Tremblay RR, Dube JY 1974 Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 10: 599605.
  • 18
    Cummings SR, Bates D, Black DM 2002 Clinical use of bone densitometry. JAMA 288: 18891897.
  • 19
    Seeman E 1997 From density to structure: Growing up and growing old on the surfaces of bone. J Bone Miner Res 12: 509520.
  • 20
    Valimaki V-V, Alfthan H, Ivaska KK, Loyttyniemi E, Pettersson K, Stenman Y-H, Valimaki M 2004 Serum estradiol, testosterone, and sex hormone-binding globulin as regulators of peak bone mass and bone turnover rate in young Finnish men. J Clin Endocrinol Metab 89: 37853789.
  • 21
    Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S 2000 Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106: 15531560.
  • 22
    Turner RT, Wakley GK, Hannon KS 1990 Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats. J Orthop Res 8: 612617.
  • 23
    Ahlborg HG, Johnell O, Turner CH, Rannevik G, Karlsson MK 2003 Bone loss and bone size after menopause. N Engl J Med 349: 327334.
  • 24
    Riggs BL, Khosla S, Melton LJ III 2002 Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23: 279302.
  • 25
    Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS 2003 Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 88: 204210.
  • 26
    Genant HK, Cann CE, Ettinger B, Gordan GS 1982 Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 97: 699705.
  • 27
    Smith MR, McGovern FJ, Zietman AL, Fallon MA, Hayden DL, Schoenfeld DA, Kantoff PW, Finkelstein JS 2001 Pamidronate to prevent bone loss in men receiving gonadotropin releasing hormone agonist therapy for prostate cancer. N Engl J Med 345: 948955.
  • 28
    Bord S, Horner A, Beavan S, Compston J 2001 Estrogen receptors alpha and beta are differentially expressed in developing human bone. J Clin Endocrinol Metab 86: 23092314.
  • 29
    Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T 1997 Expression of estrogen receptor beta in rat bone. Endocrinology 138: 45094512.
  • 30
    Modder UIL, Sanyal A, Kearns AE, Sibonga JD, Nishihara E, Xu J, O'Malley BW, Ritman EL, Riggs BL, Spelsberg TC, Khosla S 2004 Effects of loss of steroid receptor coactivator-1 on the skeletal response to estrogen in mice. Endocrinology 145: 913921.
  • 31
    Hall JM, McDonnell DP 1999 The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140: 55665578.